Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board

  09 October 2019

We propose the establishment of a new Developing Antibiotics for Resistant Targets (DART) Board to improve the targeting of incentives for antibiotic development. The DART Board would comprise clinical experts, patient advocates, and representatives from government, industry, and nonprofit organizations.

Author(s): Brad Spellberg, MD; Travis B. Nielsen, PhD; David N. Gilbert, MD; Andrew F. Shorr, MD, MPH, MBA; Eric P. Brass, MD, PhD
Smart Innovations  
Back


Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!